Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Surg Oncol. 2021 Sep 9;124(8):1390–1401. doi: 10.1002/jso.26667

Table 2.

Multivariable results for Income and Education level: Pooled effects from two mixed-effects Cox models for long-term survivala,b

Factor Model 1: HR (95% CI), p-value Model 2: HR (95% CI), p-value
Education (vs. ≥21% no high school diploma) Overall p<.0001
 13–20.9% NA 0.98 (.903,1.06), .572
 7–12.9% NA 0.97 (.894,1.05), .399
 <7% NA 0.81 (.742,.877), <.0001
Race (vs. White, non-Hispanic) Overall p=.565 Overall p=.666
 White, Hispanic 0.92 (.843,1.00), .055 0.92 (.840,1.00), .051
 Black, Non-Hispanic 1.0 (.938,1.11), .656 1.0 (.956,1.12), .381
Male gender (vs. female) 1.1 (1.09,1.20), <.0001 1.1 (1.09,1.20), <.0001
Age overall p-value (for combined linear and non-linear terms) <.0001 <.0001
Age (linear component) 0.97 (.955,.979), <.0001 0.97 (.955,.979), <.0001
Age (quadratic component) 1.1 (1.04,1.06), <.0001 1.1 (1.04,1.06), <.0001
Year of diagnosis (HR multiplies per year) 1.0 (.990,1.01), .797 1.0 (.990,1.01), .827
Income (vs. <$38K/year) Overall p<.0001
 $38,000-$47,999 0.94 (.870,1.02), .145 NA
 $48,000-$62,999 0.90 (.829,.973), .009 NA
 $63,000+ 0.80 (.738,.867), <.0001 NA
Charlson/Deyo score (HR multiplies by per unit increase) 1.2 (1.13,1.21), <.0001 1.2 (1.12,1.20), <.0001
Miles from hospital (HR multiplies by per 10-mile increment) 0.99 (.993,.998), .0001 0.99 (.994,.998), .0001
Region (vs. West) Overall p<.0001 Overall p<.0001
 East 1.2 (1.06,1.24), .001 1.1 (1.06,1.24), .001
 New England 1.0 (.952,1.10), .515 1.0 (.935,1.08), .866
 Pacific/mountain 1.1 (1.01,1.20), .031 1.1 (.993,1.19), .070
Population area (vs. Rural) Overall p=.119 Overall p=.086
 Metro 1.1 (.904,1.31), .376 1.1 (.884,1.27), .527
 Metro adjacent 1.2 (.969,1.43), .102 1.2 (.965,1.42), .109
 Not metro adjacent 1.0 (.813,1.26), .921 1.0 (.815,1.26), .907
Disease site (vs. Other) Overall p<.0001 Overall p<.0001
 C250 1.5 (1.29,1.64), <.0001 1.5 (1.29,1.64), <.0001
 C251 1.2 (1.05,1.37), .009 1.2 (1.05,1.37), .008
 C252 1.1 (.969,1.24), .141 1.1 (.969,1.24), .143
 C258 1.2 (.990,1.33), .067 1.2 (.988,1.33), .071
 C259 1.4 (1.23,1.59), <.0001 1.4 (1.22,1.58), <.0001
Tumor type (vs. carcinoid) Overall p<.0001 Overall p<.0001
 Non-secretory 1.2 (1.01,1.45), .037 1.2 (1.01,1.44), .041
 Secretory 1.4 (1.30,1.54), <.0001 1.4 (1.30,1.53), <.0001
Tumor grade (vs. well-differentiated) Overall p<.0001 Overall p<.0001
 Poor/Undifferentiated 3.8 (3.46,4.10), <.0001 3.8 (3.46,4.10), <.0001
 Moderately differentiated 1.4 (1.25,1.53), <.0001 1.4 (1.25,1.53), <.0001
 Undetermined 1.7 (1.63,1.85), <.0001 1.7 (1.63,1.85), <.0001
Tumor size ≤39mm (HR multiplies per mm increase) 1.01 (1.005,1.015), .0003 1.01 (1.005,1.016), .0002
Tumor >39mm 1.5 (1.26,1.70), <.0001 1.5 (1.27,1.71), <.0001
T stage (vs. 0/1) Overall p<.0001 Overall p<.0001
 T2 1.0 (.844,1.21), .903 1.0 (.840,1.21), .946
 T3 1.2 (1.00,1.43), .048 1.2 (1.00,1.43), .051
 T4/X 1.9 (1.57,2.18), <.0001 1.8 (1.56,2.17), <.0001
Metastasis 2.9 (2.72,3.06), <.0001 2.9 (2.72,3.07), <.0001
a

Model 1=All covariates+income (pooled adjusted R2=0.34, pooled AUC=0.79)

b

Model 2=All covariates+education (pooled adjusted R2=0.34, pooled AUC=0.79)